Andrographolide is an Alternative Treatment to Overcome Resistance in ER-Positive Breast Cancer via Cholesterol Biosynthesis Pathway

Oestrogen receptor (ER)-positive breast cancer is one of the common forms of breast cancer affecting women worldwide. ER-positive breast cancer patients are subjected to anti-oestrogen therapy such as selective oestrogen receptor modulator (SERM) and aromatase inhibitors (AIs). Recently, the emergen...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajaratinam, Harishini, Nafi, Siti Norasikin Mohd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Penerbit Universiti Sains Malaysia 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839656/
https://www.ncbi.nlm.nih.gov/pubmed/31728115
http://dx.doi.org/10.21315/mjms2019.26.5.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839656/
https://www.ncbi.nlm.nih.gov/pubmed/31728115
http://dx.doi.org/10.21315/mjms2019.26.5.2

Ejemplares similares